Century Therapeutics officer proposes $404 share sale

The proposed sale includes shares acquired through restricted stock vesting and an amount to cover a tax obligation from the equity award settlement.

Available on EDGAR 11/03/2026 - 03:32 PM EST Accepted by SEC EDGAR 11/03/2026 - 03:32 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Century Therapeutics, Inc. (IPSC) officer Douglas Carr reported a proposed sale of 266 common shares for an aggregate market value of $403.94, with an approximate sale date of November 3, 2026. The sale includes an amount needed to cover a tax obligation from a vested equity award settlement; 266 shares were listed as acquired through restricted stock vesting on November 2, 2026. Carr's prior reported sales include three transactions during August and September 2026.

Key Figures

Proposed shares to be sold: 266 shares Aggregate market value: $403.94 Prior sale shares: 275 shares +5 more

8 metrics

Proposed shares to be sold 266 shares Approximate sale date November 3, 2026

Aggregate market value $403.94 Proposed sale

Prior sale shares 275 shares August 3, 2026

Prior sale aggregate market value $543.73 August 3, 2026

Prior sale shares 254 shares September 8, 2026

Prior sale aggregate market value $520.57 September 8, 2026

Prior sale shares 1,658 shares September 14, 2026

Prior sale aggregate market value $3,200.77 September 14, 2026

Key Terms

Rule 144, Restricted Stock Vesting, vested equity award distribution

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Vesting financial

"Restricted Stock Vesting"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

vested equity award distribution financial

"settlement of a vested equity award distribution"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many IPSC shares does Douglas Carr plan to sell?

Douglas Carr, an officer, reported a proposed sale of 266 common shares for an aggregate market value of $403.94, with an approximate sale date of November 3, 2026.

What prior IPSC sales did Douglas Carr report?

The reported sales include 275 shares with an aggregate market value of $543.73 on August 3, 2026; 254 shares with an aggregate market value of $520.57 on September 8, 2026; and 1,658 shares with an aggregate market value of $3,200.77 on September 14, 2026.

What tax obligation is associated with Douglas Carr's proposed IPSC sale?

The sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001867173
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Century Therapeutics, Inc.
SEC File Number	001-40498
Address of Issuer	25 N 38TH STREET, 12TH FLOOR PHILADELPHIA PENNSYLVANIA 19104
Phone	215-981-4000
Name of Person for Whose Account the Securities are To Be Sold	Carr Douglas
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	266	403.94	181075321	11/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/02/2026	Restricted Stock Vesting	Issuer			266	11/02/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Douglas Carr 25 N 38th Street 12th Floor Philadelphia PA 19104	Common	08/03/2026	275	543.73
Douglas Carr 25 N 38th Street 12th Floor Philadelphia PA 19104	Common	09/08/2026	254	520.57
Douglas Carr 25 N 38th Street 12th Floor Philadelphia PA 19104	Common	09/14/2026	1658	3200.77

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	11/03/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jennifer Ruchti, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Douglas Carr
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)